A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation (Q30318258)

17 June 2017

title

A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation (English)

1 reference

17 June 2017

Peggy Stock

2

1 reference

ORCID Public Data File 2021

author name string

Sandra Pelz

series ordinal

1

1 reference

17 June 2017

Sandra Brückner

series ordinal

3

1 reference

17 June 2017

Bruno Christ

series ordinal

4

1 reference

17 June 2017

language of work or name

English

0 references

publication date

13 November 2011

1 reference

Experimental Cell Research

17 June 2017

published in

1 reference

17 June 2017

volume

318

1 reference

17 June 2017

issue

3

1 reference

17 June 2017

page(s)

276-287

1 reference

Non-alcoholic steatohepatitis: an overview

17 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Hepatic microcirculation in fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Non-alcoholic fatty liver disease: the mist gradually clears

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Pathogenesis of steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Molecular mechanisms of hepatic fibrogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Reversal of hepatic fibrosis -- fact or fantasy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Liver fibrosis -- from bench to bedside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Measurement of protein using bicinchoninic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Hepatic transplantation of mesenchymal stem cells in rodent animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Methionine synthase. a possible prime site of the ethanolic lesion in liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

The role of phosphatidylcholine biosynthesis in the secretion of lipoproteins from hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein B secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

The physiological and molecular regulation of lipoprotein assembly and secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

New approaches to target microsomal triglyceride transfer protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Alkaline phosphatase: beyond the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Acute-phase serum amyloid A as a marker of insulin resistance in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Serum amyloid A, the major vertebrate acute-phase reactant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

NASH animal models: are we there yet?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Cell fusion is the principal source of bone-marrow-derived hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Pluripotency of mesenchymal stem cells derived from adult marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Tracking of human cells in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Human hepatocyte transplantation: worldwide results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Present status and perspectives of cell-based therapies for liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

The bone marrow functionally contributes to liver fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Differential anti-inflammatory and anti-fibrotic activity of transplanted mesenchymal vs. hematopoietic stem cells in carbon tetrachloride-induced liver injury in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.005

10.1016/J.YEXCR.2011.11.005

7 January 2021

Identifiers

DOI

1 reference

17 June 2017

1 reference